Area of research
Oncology · Surgery
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, and Acute Myeloid Leukemia Research.
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
Additional file 1 of Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
Additional file 1 of Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
Primary and secondary metastatic dissemination: multiple routes to cancer-related death
MetInfilt: A prospective trial highlighting the importance of the histological growth pattern in brain metastases
Preliminary effectiveness of social prescription and virtual patient information in increasing tertiary prevention among cancer patients (ESPRIT): protocol for a single-centre, randomised controlled pilot trial
NSCLC mit synchroner Oligometastasierung zum Zeitpunkt Erstdiagnose. Einfluss unterschiedlicher Systemtherapien auf die Prognose. Eine BZKF-Analyse.
NSCLC mit synchroner Oligometastasierung zum Zeitpunkt Erstdiagnose. Einfluss von System- und Lokaltherapie auf die Prognose. Eine BZKF-Analyse
Overcoming challenges in obtaining informed consent in cancer clinical trials
OGCT-04 PROSPECTIVE IMAGING-GUIDED BIOPSY TRIAL OF THE MACRO METASTASIS-BRAIN PARENCHYMA INTERFACE (METINFILT STUDY)
P11.39.B IMPORTANCE OF THE HISTOLOGICAL GROWTH PATTERN IN BRAIN METASTASES. A PROSPECTIVE IMAGING-GUIDED BIOPSY TRIAL
Imaging–guided prospective biopsy trial of the macro metastasis–brain parenchyma interface highlighting the importance of the histological growth pattern in brain metastases
How to improve informed consent processes in clinical trials with cancer patients: a qualitative analysis of multidisciplinary experts’ perspectives
611O Updated results from BNT211-01 (NCT04503278), an ongoing, first-in-human, phase I study evaluating safety and efficacy of CLDN6 CAR T cells and a CLDN6-encoding mRNA vaccine in patients with relapsed/refractory CLDN6+ solid tumors
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patients
A Phase 1, Open-Label, Dose Escalation and Dose Expansion Study of Cln-049 for the Treatment of Acute Myeloid Leukemia Patients with Measurable Residual Disease
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial
Low-dose azacitidine, pioglitazone and all-trans retinoic acid is safe in patients aged ≥ 60 years with acute myeloid leukemia refractory to standard induction chemotherapy (AMLSG 26-16/AML-ViVA): results of the safety run-in phase
CLDN6 CAR-T cell therapy of relapsed/refractory solid tumors ± a CLDN6-encoding mRNA vaccine: Dose escalation data from the BNT211-01 phase 1 trial using an automated product.
Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre
Identification of Disparities in Personalized Cancer Care—A Joint Approach of the German WERA Consortium
Abstract CT002: BNT211: A Phase I trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors
Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature
Biomodulatory therapy induces durable remissions in multi-system Langerhans cell histiocytosis
All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma
Association of epidemiological and clinical features with PCR cycle threshold values of SARS-CoV-2 infection: a cross-sectional study
Thorakale Onkologie – metastasierte Stadien
Mapping the Regional Distribution of Molecular Tumor Board Patients and Identifying White Spots in our Catchment Area – a Joint Approach of the CCC WERA Alliance
Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson’s disease: Balancing immunosuppression
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Oncology · Surgery →